Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vivani Medical, Inc.VANI · Entity 6636 | Director | June 24, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vivani Medical, Inc.
Report date June 24, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.22 · Expires 2036-06-23 | Direct | 36,516 |
Reported balance
After 2026-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-24 · Grant · Acquired 36,516 · Balance 36,516 F2: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F1: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.
F2: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2026 Filed Jun 25, 2026 23:38 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 36,516 | $1.22 Strike: $1.22 | $44,549.52 |
DisclosureSEC source: 0001753926-26-001066 · form4.xml · derivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,516 Underlying: Common Stock · 36,516 shares Expires 2036-06-23 F2 · price: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · derivative.underlying_shares: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. Read SEC document |
| December 29, 2025 Filed Dec 31, 2025 14:00 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 20,000 | $1.23 | $24,600.00 |
DisclosureSEC source: 0001753926-25-002003 · form4.xml · nonDerivative · entry 2 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,170 F2 · kind: Individual purchased shares on the open market. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| June 24, 2025 Filed Jun 27, 2025 00:33 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 35,135 | $1.27 Strike: $1.27 | $44,621.45 |
DisclosureSEC source: 0001753926-25-001037 · primary_doc.xml · derivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,135 Underlying: Common Stock · 35,135 shares Expires 2035-06-23 F2 · price: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · derivative.underlying_shares: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. Read SEC document |
| July 08, 2024 Filed Dec 31, 2025 14:00 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-25-002003 · form4.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,170 F1 · date: A Form 4 to disclose the gift of 20,000 shares made to a non-affiliated entity on 07/08/2024 was inadvertently not previously filed. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 20:45 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 34,839 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-24-001189 · ownership.xml · derivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,839 Underlying: Common Stock · 34,839 shares Expires 2034-06-26 F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's non-employee director compensation policy. F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 23:31 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 32,121 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001753926-23-000815 · form_4.xml · derivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,121 Underlying: Common Stock · 32,121 shares Expires 2033-06-15 F2 · derivative.exercise_date: Options vest monthly over a one-year period. F1 · balance_after: Awarded as compensation for serving on the Board of Directors. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 01:32 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 10,000 | $1.30 | $12,980.00 |
DisclosureSEC source: 0001753926-23-000794 · form_4.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,170 F1 · ownership.direct: Represents shares of common stock purchased by Mr. Mendelsohn on the open market. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherWarrants · Derivative | 25,927 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · derivative · entry 7 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 25,927 Underlying: Common Stock · 25,927 shares Expires 2023-12-14 F5 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. F6 · ownership.nature: Represents shares of common stock underlying a warrant owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of the limited liability company and therefore 5,185 shares of common stock held by the limited liability company, which are beneficially owned by other members of the limited liability company. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · derivative · entry 6 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2030-11-19 F4 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · derivative · entry 5 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2029-11-11 F4 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · derivative · entry 4 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2028-11-13 F4 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock | 747,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · nonDerivative · entry 3 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 747,387 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. F3 · ownership.nature: Represents shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of the limited liability company and therefore 149,478 shares of common stock held by the limited liability company, which are beneficially owned by other members of the limited liability company. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock | 150,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · nonDerivative · entry 2 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trusts Disclosed balance after: 150,930 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. F2 · ownership.nature: Represents five trusts, each one established for a separate grandchild of the Reporting Person, each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock | 178,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,170 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. Read SEC document |
| April 13, 2021 Filed Apr 29, 2022 17:43 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GiftCommon Stock | 16,724 | $8.39 | $140,314.36 |
DisclosureSEC source: 0001753926-22-000609 · ownership.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Mr. Mendelsohn gifted these shares to Mendelsohn Investment Services LLC, an entity owned by his two adult children. Mr. Mendelsohn has neither an interest in or any voting power in this entity. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:16 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option(right to buy) · Derivative | 56,685 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001209191-19-034730 · doc4.xml · derivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,685 Underlying: Common Stock · 56,685 shares Expires 2029-06-04 F1 · derivative.exercise_date: The stock options have a 10-year term and fully vest on the earlier of annual grant date anniversary or the date of the next annual shareholder's meeting. F2 · derivative.underlying_shares: Awarded as compensation for serving on the Board of Directors and its committees. Read SEC document |
| June 02, 2018 Filed Jun 6, 2018 01:00 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon Qualified Stock Option (right to buy) · Derivative | 25,970 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-18-011318 · rdgdoc.xml · derivative · entry 2 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,970 Underlying: Common Stock · 25,970 shares Expires 2028-06-02 F1 · derivative.underlying_shares: Awarded as compensation for serving on the Board of Directors and its committees. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:00 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCOMMON STOCK | 29,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-011318 · rdgdoc.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,807 F1 · shares: Awarded as compensation for serving on the Board of Directors and its committees. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 22:51 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCOMMON STOCK | 49,488 | $1.17 | $57,999.94 |
DisclosureSEC source: 0001615774-17-002933 · s106450_form4.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,365 F1 · shares: Awarded to Mr. Mendelsohn as compensation for serving on the Board of Directors and its committees. F2 · price: Price per share constitutes an average closing price of Company's stock for the preceding twenty trading days on its principal exchange. Read SEC document |
| September 26, 2016 Filed Feb 2, 2017 01:40 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GiftCommon Stock | 809,002 | $3.25 | $2,629,256.50 |
DisclosureSEC source: 0001615774-17-000315 · s105209.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,877 F1 · shares: Mendelsohn Family Enterprises, LLC (MFE), a limited liability company that is 80% owned by Mr. Mendelsohn and 20% by Mr. Mendelsohn's two adult sons, transferred for no consideration 809,002 shares of the Company's common stock that it held of record, as a gift made in connection with estate planning, to Mendelsohn Investment Services LLC, a limited liability company wholly owned and managed by Mr. Mendelsohn's two adult sons. F2 · price: The closing price of Company's common stock on Nasdaq on the date of transfer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.